Skip to main content

#160725

Xist-TetOP mutant: DeltaB+1/2C cell line

Cat. #160725

Xist-TetOP mutant: DeltaB+1/2C cell line

Cat. #: 160725

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Mouse

Model: Stem Cells

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sim?„ƒo Teixeira da Rocha

Institute: Instituto de Medicina Molecular Jo?„ƒo Lobo Antunes

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Xist-TetOP mutant: DeltaB+1/2C cell line
  • Research fields: Genetics;Stem cell biology
  • Tool sub type: Continuous
  • Parental cell: Xist-TetOP XY ESCs (Wutz et al., 2002 PMID: 11780141)
  • Organism: Mouse
  • Growth properties: Disruption of Polycomb recruitment to the inactive X-chromosome.
  • Model: Stem Cells
  • Conditional: No
  • Conditional description: Inducible through addition of doxycycline (1.5 ÎĚ?Ÿg/ml) to the medium
  • Description: Deletion of mouse Xist lncRNA to dissect specific RNA modules in the process of X-chromosome inactivation.
  • Production details: CRISPR/Cas9 genome editing of the Xist-TetOP XY ESC line
  • Additional notes: Cancer Research Technology Limited (trading research tools as Ximbio) has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here. This license from ERS Genomics Ltd allows Ximbio to develop and commercialise CRISPR-Cas9 modified cell lines for research use only. Ximbio can provide these modified CRISPR-Ca...
  • Recommended controls: Xist-TetOP XY ESCs (Wutz et al., 2002 PMID: 11780141)

Target Details

  • Target: Mouse Xist lncRNA

Handling

  • Format: Frozen
  • Growth medium: ESCs grow in feeder-free classic ESC medium DMEM media containing 15% fetal bovine serum (FBS), 103 U/ml leukemia inhibitor factor (LIF), 10-4 mM 2-mercaptoethanol, 50 U/ml penicillin, and 50 ?g/ml of streptomycin (Gibco) at 37?‚°C in 5-8% CO2. Medium is changed daily Inducible expression of Xist driven by a TetO promoter is achieved by adding DOX (1.5 ?g/ml).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Xist-TetOP mutant: ?B cell line ; Xist-TetOP mutant: ?C cell line

References

  • Bousard et al. 2019. EMBO Rep. 20(10):e48019. PMID: 31456285.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.